First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
Original Article from The New England Journal of Medicine — First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 22, 2017
|
| In: |
The New England journal of medicine
Year: 2017, Jahrgang: 376, Heft: 25, Pages: 2415-2426 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1613493 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa1613493 Verlag, Volltext: http://www.nejm.org/doi/10.1056/NEJMoa1613493 
|
| Verfasserangaben: | David P. Carbone, Martin Reck, Luis Paz-Ares, Benjamin Creelan, Leora Horn, Martin Steins, Enriqueta Felip, Michel M. van den Heuvel, Tudor-Eliade Ciuleanu, Firas Badin, Neal Ready, T. Jeroen N. Hiltermann, Suresh Nair, Rosalyn Juergens, Solange Peters, Elisa Minenza, John M. Wrangle, Delvys Rodriguez-Abreu, Hossein Borghaei, George R. Jr Blumenschein, Liza C. Villaruz, Libor Havel, Jana Krejci, Jesus Corral Jaime, Han Chang, William J. Geese, Prabhu Bhagavatheeswaran, Allen C. Chen, Mark A. Socinski |
| Zusammenfassung: | Original Article from The New England Journal of Medicine — First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer |
|---|---|
| Beschreibung: | Gesehen am 21.12.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1613493 |